iopromide has been researched along with Hilar Cholangiocarcinoma in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the enhancement pattern of hilar cholangiocarcinoma on contrast-enhanced ultrasound (CEUS) with that on contrast-enhanced computed tomography (CECT)." | 1.36 | Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography. ( Chen, LD; Lin, MX; Liu, GJ; Lu, MD; Wang, Z; Xie, XH; Xie, XY; Xu, HX; Xu, ZF, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, HX | 1 |
| Chen, LD | 1 |
| Xie, XY | 1 |
| Xie, XH | 1 |
| Xu, ZF | 1 |
| Liu, GJ | 1 |
| Lin, MX | 1 |
| Wang, Z | 1 |
| Lu, MD | 1 |
1 other study available for iopromide and Hilar Cholangiocarcinoma
| Article | Year |
|---|---|
Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Contrast | 2010 |